Skip to main content
Equibles

QGEN · Qiagen N.V. · Metrics

Track QGEN — free

Use QGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$43.33 -1.05 (-2.37%) At close · Sep 18
Russell 1000 member Rebalance outlook locked
Market Cap
$8.95B
Shares
206.50M

QGEN metrics

53 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$43.33
Market cap
$8.95B

Price action

20 metrics
Price change (1W)
+2.0%
Price change (30D)
-1.7%
Price change (3M)
+17.3%
Price change (6M)
+8.5%
Price change (YTD)
-3.6%
Price change (1Y)
-5.3%
Trailing year
Price change (5Y)
-22.7%
52-week high
$55.66
52-week low
$32.63
Change from 52-week high
-22.2%
Change from 52-week low
+32.8%
Annualized volatility
34.6%
Annualized volatility (3M)
36.3%
Beta
0.4
RSI (14D)
52.7
Price vs SMA 50
+2.0%
Price vs SMA 200
+1.8%
Avg volume (3M)
2.79M
Relative volume
0.6
Average dollar volume
$116.47M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
206.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.4
reciprocal yield 42.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
62.2%
Operating margin
22.3%
Trailing 12 months
Net margin
20.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.42

Growth

11 metrics
Revenue growth YoY
+5.7%
Year over year
Net income growth YoY
+408.3%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+424.3%
Shares change YoY
-2.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-0.8%
Revenue CAGR (5Y)
+2.2%
EPS CAGR (3Y)
+1.8%
EPS CAGR (5Y)
+4.9%
FCF CAGR (3Y)
-8.2%
FCF CAGR (5Y)
+6.9%

Quality

14 metrics
Return on equity
11.2%
Return on assets
6.8%
Debt / equity
—
Current ratio
3.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$839.00M
Total assets
$6.28B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
341
13F filer change QoQ
-13
Institutional ownership
72.3%

Short interest

3 metrics
Short interest
3.6%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1015820 CUSIP N72482156 13F (30d) 12 filings 11 filers Visit website Investor relations